Karuna Therapeutics to Present at Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Karuna Therapeutics Inc. (KRTX) PT Raised to $175 at Oppenheimer
November 8, 2021 6:33 AM ESTOppenheimer analyst Jay Olson raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $175.00 (from $148.00) while maintaining an Outperform rating.
The analyst commented, "KRTX reported 3Q21 results with OpEx of $51M and cash of ~$500M. We highlight key progress and catalysts,... More
